日本消化器病学会アーカイブシステム

セッション	検索結果は4件です。 The molecular classification of pancreatic neoplasia Hruban　Ralph H.（The Johns Hopkins University School of Medicine, USA）　The exomes of all of the major tumor types that arise in the pancreas have been sequenced, and at the genetic level pancreatic cancer is now one of the best understood of all of the cancers. The chal... 第100回日本消化器病学会総会＞ II　Challenge to the pancreatic and biliary cancers　1. Pancreatic and biliary cancers―Challenge to the pathogenesis Pathology of bile duct carcinoma with emphasis on pre-invasive lesions Nakanuma　Yasuni（Department of Human Pathology, Kanazawa University Graduate School of Medicine/Department of Pathology, Shizuoka Cancer Center, Japan） Bile duct carcinoma（cholangiocarcinoma）remains an intractable malignancy and is clincially detectable at the advanced stage in a majority of cases. Histologically, this carcinoma shows usually tubular... 第100回日本消化器病学会総会＞ II　Challenge to the pancreatic and biliary cancers　1. Pancreatic and biliary cancers―Challenge to the pathogenesis Significance of CXC Chemokines/CXCR2 Axis in Pancreatic Cancer Progression Ijichi　Hideaki（Department of Gastroenterology, The University of Tokyo, Japan） Pancreatic cancer is still one of the most deadly cancers. Histological feature of this cancer is abundant stroma including marked fibrosis, desmoplasia, which might be contributing to the poor progno... 第100回日本消化器病学会総会＞ II　Challenge to the pancreatic and biliary cancers　1. Pancreatic and biliary cancers―Challenge to the pathogenesis Involvement of epithelial to mesenchymal transition and its related molecules in the development of pancreatic ductal adenocarcinoma Satoh　Kennichi（Division of Cancer Stem Cell, Miyagi Cancer Center Research Institute, Japan）　Epithelial to mesenchymal transition（EMT）plays a pivotal role in cancer cell invasion and metastasis. In addition, recent studies show the association of EMT with chemoresistance and property of canc... 第100回日本消化器病学会総会＞ II　Challenge to the pancreatic and biliary cancers　1. Pancreatic and biliary cancers―Challenge to the pathogenesis

セッション

検索結果は4件です。

The molecular classification of pancreatic neoplasia: Hruban　Ralph H.（The Johns Hopkins University School of Medicine, USA）
　The exomes of all of the major tumor types that arise in the pancreas have been sequenced, and at the genetic level pancreatic cancer is now one of the best understood of all of the cancers. The chal...
第100回日本消化器病学会総会＞ II　Challenge to the pancreatic and biliary cancers　1. Pancreatic and biliary cancers―Challenge to the pathogenesis
Pathology of bile duct carcinoma with emphasis on pre-invasive lesions: Nakanuma　Yasuni（Department of Human Pathology, Kanazawa University Graduate School of Medicine/Department of Pathology, Shizuoka Cancer Center, Japan）
Bile duct carcinoma（cholangiocarcinoma）remains an intractable malignancy and is clincially detectable at the advanced stage in a majority of cases. Histologically, this carcinoma shows usually tubular...
第100回日本消化器病学会総会＞ II　Challenge to the pancreatic and biliary cancers　1. Pancreatic and biliary cancers―Challenge to the pathogenesis
Significance of CXC Chemokines/CXCR2 Axis in Pancreatic Cancer Progression: Ijichi　Hideaki（Department of Gastroenterology, The University of Tokyo, Japan）
Pancreatic cancer is still one of the most deadly cancers. Histological feature of this cancer is abundant stroma including marked fibrosis, desmoplasia, which might be contributing to the poor progno...
第100回日本消化器病学会総会＞ II　Challenge to the pancreatic and biliary cancers　1. Pancreatic and biliary cancers―Challenge to the pathogenesis
Involvement of epithelial to mesenchymal transition and its related molecules in the development of pancreatic ductal adenocarcinoma: Satoh　Kennichi（Division of Cancer Stem Cell, Miyagi Cancer Center Research Institute, Japan）
　Epithelial to mesenchymal transition（EMT）plays a pivotal role in cancer cell invasion and metastasis. In addition, recent studies show the association of EMT with chemoresistance and property of canc...
第100回日本消化器病学会総会＞ II　Challenge to the pancreatic and biliary cancers　1. Pancreatic and biliary cancers―Challenge to the pathogenesis